Faculty Opinions recommendation of P-glycoprotein and breast cancer resistance protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availability.
2013 ◽
Vol 134
(6)
◽
pp. 1484-1494
◽
Keyword(s):